Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores

[1]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[2]  K. Anstrom,et al.  Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial , 2017, JAMA.

[3]  J. Kautzner,et al.  Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis , 2017, European journal of heart failure.

[4]  N. Chattipakorn,et al.  Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine , 2017, Scientific Reports.

[5]  Yong Wang,et al.  Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure , 2016, European heart journal.

[6]  H. Ardehali,et al.  Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron. , 2016, Circulation research.

[7]  Yan-zhong Chang,et al.  Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury , 2016, Cell Death & Disease.

[8]  Hailing Li,et al.  Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca(2+)-ATPase in diabetic rats. , 2016, Biochimie.

[9]  P. Ponikowski,et al.  Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials , 2016, European journal of heart failure.

[10]  A. Thakur,et al.  Reduction in mitochondrial iron alleviates cardiac damage during injury , 2016, EMBO molecular medicine.

[11]  M. Kruszewski,et al.  Does myocardial iron load determine the severity of heart insufficiency? , 2015, International journal of cardiology.

[12]  P. Ponikowski,et al.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† , 2014, European heart journal.

[13]  Wei Zhang,et al.  ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders , 2013, Haematologica.

[14]  Arineh Khechaduri,et al.  Heme levels are increased in human failing hearts. , 2013, Journal of the American College of Cardiology.

[15]  P. Ponikowski,et al.  Iron deficiency in chronic heart failure: an international pooled analysis. , 2013, American heart journal.

[16]  P. Ponikowski,et al.  Iron status in patients with chronic heart failure. , 2013, European heart journal.

[17]  C. Hoppel,et al.  Mitochondrial dysfunction in heart failure , 2013, Heart Failure Reviews.

[18]  H. Tsutsui,et al.  Oxidative stress and heart failure. , 2011, American journal of physiology. Heart and circulatory physiology.

[19]  D. Farmakis,et al.  Contemporary Reviews in Cardiovascular Medicine Iron Overload Cardiomyopathy in Clinical Practice , 2011 .

[20]  P. Poole‐Wilson,et al.  Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. , 2011, Journal of the American College of Cardiology.

[21]  C. D. dos Remedios,et al.  Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. , 2011, Journal of the American College of Cardiology.

[22]  P. Ponikowski,et al.  Iron deficiency: an ominous sign in patients with systolic chronic heart failure. , 2010, European heart journal.

[23]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[24]  M. Mączewski,et al.  Effect of Metoprolol and Ivabradine on Left Ventricular Remodelling and Ca 21 Handling in the Post-infarction Rat Heart , 2022 .

[25]  M. Mączewski,et al.  Hypercholesterolemia exacerbates ventricular remodeling in the rat model of myocardial infarction. , 2006, Journal of cardiac failure.

[26]  Sheryl E. Koch,et al.  L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy , 2003, Nature Medicine.

[27]  A. Feldman,et al.  Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. , 2003, American journal of physiology. Heart and circulatory physiology.

[28]  B. Ames,et al.  Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Fitzpatrick.  Getting to the heart of it. , 2001, Nursing management.

[30]  G. Oudit,et al.  Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. , 1999, Circulation research.

[31]  J. Schaper,et al.  Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.

[32]  E. Werner,et al.  Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. , 1992, Experimental hematology.

[33]  M. Pfeffer,et al.  Progressive ventricular remodeling in rat with myocardial infarction. , 1991, The American journal of physiology.